Literature DB >> 9420672

Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging.

S Maurea1, A Cuocolo, L Pace, E Nicolai, A Nappi, M Imbriaco, B Trimarco, M Salvatore.   

Abstract

BACKGROUND: We compared rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile (MIBI) cardiac imaging in 29 men with angiographically proven coronary artery disease and regional ventricular dysfunction. Left ventricular ejection fraction at radionuclide angiography was 35% +/- 9%. METHODS AND
RESULTS: Regional left ventricular wall motion was assessed on gated 99mTc MIBI images according to a 3-point scale (0 = normal, 1 = hypokinetic, 2 = akinetic or dyskinetic). 201Tl and 99mTc MIBI uptake values were analyzed quantitatively. A total of 435 myocardial segments were classified on the basis of wall motion analysis into three groups: group 1 (normal wall motion; n = 201), group 2 (hypokinetic; n = 132), and group 3 (akinetic or dyskinetic; n = 102). 201Tl and 99mTc MIBI uptake values were significantly higher in groups 1 and 2 compared with group 3 (p < 0.05) and in group 1 compared with group 2 (p < 0.05). When 201Tl and 99mTc MIBI uptake values were directly compared, no significant differences in group 1 and 2 were observed. In group 3, 99mTc MIBI uptake (67% +/- 14%) was significantly lower (p < 0.001) than initial (72% +/- 11%) and delayed 201Tl uptake (73% +/- 12%).
CONCLUSION: Thus rest-redistribution 201Tl and resting 99mTc MIBI cardiac imaging reflect the severity of left ventricular dysfunction in coronary artery disease. However, in segments with severely impaired regional ventricular function, 201Tl uptake is significantly higher than 99mTc MIBI uptake.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9420672     DOI: 10.1007/bf02940013

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

1.  Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions.

Authors:  T Mori; K Minamiji; H Kurogane; K Ogawa; Y Yoshida
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

2.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?

Authors:  R S Beanlands; F Dawood; W H Wen; P R McLaughlin; J Butany; G D'Amati; P P Liu
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

3.  Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy.

Authors:  A Cuocolo; S Maurea; L Pace; E Nicolai; A Nappi; M Imbriaco; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-12

4.  Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis.

Authors:  S Maurea; A Cuocolo; L Pace; E Nicolai; A Nappi; M Imbriaco; C Morisco; M Chiariello; B Trimarco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1993-06

5.  Comparison between exercise and trans-oesophageal atrial pacing in patients with coronary artery disease: technetium-99m methoxy isobutyl isonitrile simultaneous evaluation of ventricular function and myocardial perfusion.

Authors:  A Cuocolo; M Santomauro; L Pace; L Celentano; A Nappi; E Nicolai; M Chiariello; M Salvatore
Journal:  Eur J Nucl Med       Date:  1992

6.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.

Authors:  R O Bonow; V Dilsizian; A Cuocolo; S L Bacharach
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

7.  The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability.

Authors:  P Marzullo; G Sambuceti; O Parodi
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

8.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia.

Authors:  V Dilsizian; R O Bonow; R O Cannon; C M Tracy; D F Vitale; C L McIntosh; R E Clark; S L Bacharach; M V Green
Journal:  Am J Cardiol       Date:  1988-06-01       Impact factor: 2.778

10.  A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients.

Authors:  M Dondi; F Tartagni; F Fallani; S Fanti; M Marengo; I DiTommaso; Q F Zheng; N Monetti
Journal:  Eur J Nucl Med       Date:  1993-01
View more
  5 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

3.  Can technetium 99m-labeled sestamibi track myocardial viability?

Authors:  J E Udelson
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

4.  Quantitative comparison of single-isotope and dual-isotope stress-rest single-photon emission computed tomographic imaging for reversibility of defects.

Authors:  H M Siebelink; D Natale; A J Sinusas; F J Wackers
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

5.  Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis.

Authors:  K Takehana; M Ruiz; F D Petruzella; D D Watson; G A Beller; D K Glover
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.